Annelise Soulier – Senior Scientist
Annelise joined Prokarium in 2013 as senior scientist to develop Prokarium’s leading travellers’ diarrhoea vaccine, Typhetec and a Clostridium difficile vaccine supported by a UK government grant in Synthetic Biology. Since the recent success of Typhetec’s preclinical studies, the vaccine is currently being taken into a Phase I clinical study and Prokarium is expanding to develop a Chlamydia trachomatis vaccine and a swine diarrhoea vaccine. Prior to her role at Prokarium, Annelise was a postdoctoral fellow in immunology at the Institute of Biomedical Research of the University of Birmingham, UK. She completed her Ph.D. in microbiology in 2007 at The Institute for Animal Health, UK. Annelise originally hails from Provence in Southern France.